| Trial registration number
|
NCT04712357 |
Full text link
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04712357
|
First author
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Aldo AM Lima, Ph.D.
|
Contact
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
alima@ufc.br
|
Registration date
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-01-15
|
Recruitment status
Last imported at : Jan. 6, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- patient is > 18 years old
- patient diagnosed with covid-19
|
Exclusion criteria
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
- patient is already receiving some of the study drugs
- there is a hospitalization plan in the next 24h
- some study treatment is contraindicated
- patient has hiv infection
- patient has vhb infection
- patient lives in another city or state
- female patient, pregnant
|
Number of arms
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
3
|
Funding
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Universidade Federal do Ceara
|
Inclusion age min
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Brazil
|
Type of patients
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
No restriction on type of patients
|
Severity scale
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
0: No restriction on type of patients
|
Total sample size
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
219
|
primary outcome
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
The time to recovery, defined at day 7 days follow up after enrollment, on which a patient met the criteria for category 1, 2, or 3 on the eight-category ordinal scale.
|
Notes
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Jan. 17, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1496, "treatment_name": "Emtricitabine+tenofovir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1277, "treatment_name": "Tenofovir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|